Signum Biosciences

THE PROMISE OF PP2A. Discovering novel therapeutics for the treatment of neurodegenerative disorders. Through research on protein networks that control biological systems, Signum is developing therapeutic agents for Alzheimers, Parkinsons, and other neurodegenerative diseases. Signum Biosciences spin out, Signum Dermalogix, is focused on developing new and innovative dermatological products with a commitment to quality, efficacy and safety. Research and Funding Provided by.

OVERVIEW

This web page signumbiosciences.com currently has an average traffic classification of zero (the lower the more traffic). We have scanned eight pages inside the site signumbiosciences.com and found twenty-three websites associating themselves with signumbiosciences.com. There are two contacts and directions for signumbiosciences.com to help you reach them. This web page signumbiosciences.com has been on the internet for one thousand one hundred and eighty-nine weeks, eighteen days, eight hours, and fifty-five minutes.
Pages Crawled
8
Links to this site
23
Contacts
2
Locations
2
Online Since
Feb 2002

SIGNUMBIOSCIENCES.COM RANKINGS

This web page signumbiosciences.com has seen alternating levels of traffic all through the year.
Traffic for signumbiosciences.com

Date Range

1 week
1 month
3 months
This Year
Last Year
All time
Traffic ranking (by month) for signumbiosciences.com

Date Range

All time
This Year
Last Year
Traffic ranking by day of the week for signumbiosciences.com

Date Range

All time
This Year
Last Year
Last Month

SIGNUMBIOSCIENCES.COM HISTORY

This web page signumbiosciences.com was created on February 13, 2002. This domain was last updated on the date of December 20, 2012. It will expire on February 13, 2016. It is now one thousand one hundred and eighty-nine weeks, eighteen days, eight hours, and fifty-five minutes young.
REGISTERED
February
2002
UPDATED
December
2012
EXPIRED
February
2016

LENGTH OF LIFE

22
YEARS
9
MONTHS
19
DAYS

LINKS TO WEB SITE

Nerium Internationals Official Blog

3 Tips to Help You Unleash Your Inner Entrepreneur. Jeff Olson, Founder and CEO of Nerium International , is a dynamic and visionary leader who has served in many executive roles across different business channels and companies. This is How You Lead with Impact.

Signum Dermalogix Focused on developing new and innovative dermatological products with a commitment to quality, efficacy and safety.

Focused on developing new and innovative dermatological products with a commitment to quality, efficacy and safety. Developing Ingredients and Compounds for Skin Care. Testing and development services in dermatology.

WHAT DOES SIGNUMBIOSCIENCES.COM LOOK LIKE?

Desktop Screenshot of signumbiosciences.com Mobile Screenshot of signumbiosciences.com Tablet Screenshot of signumbiosciences.com

CONTACTS

PERFECT PRIVACY, LLC

12808 Gran Bay Parkway West

Jacksonville, FL, 32258

US

PERFECT PRIVACY, LLC

12808 Gran Bay Parkway West

Jacksonville, FL, 32258

US

SIGNUMBIOSCIENCES.COM HOST

I detected that a single root page on signumbiosciences.com took two thousand and fifty-nine milliseconds to come up. I could not detect a SSL certificate, so therefore our crawlers consider this site not secure.
Load time
2.059 secs
SSL
NOT SECURE
Internet Protocol
76.12.133.162

NAME SERVERS

ns100.worldnic.com
ns99.worldnic.com

SERVER OS AND ENCODING

I diagnosed that this website is utilizing the Microsoft-IIS/7.5 os.

PAGE TITLE

Signum Biosciences

DESCRIPTION

THE PROMISE OF PP2A. Discovering novel therapeutics for the treatment of neurodegenerative disorders. Through research on protein networks that control biological systems, Signum is developing therapeutic agents for Alzheimers, Parkinsons, and other neurodegenerative diseases. Signum Biosciences spin out, Signum Dermalogix, is focused on developing new and innovative dermatological products with a commitment to quality, efficacy and safety. Research and Funding Provided by.

CONTENT

This web page signumbiosciences.com has the following in the web page, "Discovering novel therapeutics for the treatment of neurodegenerative disorders." We viewed that the website also stated " Through research on protein networks that control biological systems, Signum is developing therapeutic agents for Alzheimers, Parkinsons, and other neurodegenerative diseases." It also said " Signum Biosciences spin out, Signum Dermalogix, is focused on developing new and innovative dermatological products with a commitment to quality, efficacy and safety. Research and Funding Provided by."

SEEK SUBSEQUENT WEBSITES

Biuro aktuarialne Aktuariusz - Wyceny rezerw pracowniczych

Biuro Usług Aktuarialnych Signum istnieje od 2004 roku. Jesteśmy jednym z najbardziej doświadczonych i uznanych firm zajmujących się doradztwem aktuarialnym. W ofercie biura usługi aktuarialne. Biuro Aktuarialne Signum specjalizuje się w usługach aktuarialnych. To wszechstronny specjalista, zajmujący się szacowaniem ryzyka oraz wartości bieżącej projektów finansowych, w szczególności długoterminowych lub obarczonych ryzykiem. Ze szczególnym naciskiem na wycenę .

Signumbloggen Katolsk orientering om kyrka, kultur och samhälle

Katolsk orientering om kyrka, kultur och samhälle. En velpelle till påve i Morettis nya film. I övrigt skildras kardinalerna mest som välmenande och aningen världsfrånvända äldre herrar. Rysk-ortodoxa och katoliker i gemensamt försvar av kristna värden. Ortodoxa och katoliker har bildat en front för att försvara de kristna värdena i det moderna samhället, enligt patriarken. Den gemensamma uppfattningen i flera frågor är mycket viktig för konsolideringen av det ryska samhället .

Signum Bildtechnik

Bildtechnik GmbH - Ruedesheimer Str. 21 - 80686 Munich - Germany - 49-89-547063-0 - www.